Engineered extracellular vesicles for ischemic stroke treatment-The Innovation

See the unseen. Change the unchanged.

The Innovation — published by Cell Press in partnership with members of the Youth
Innovation Promotion Association (YIPA),a part of the Chinese Academy of
Sciences—is a new broad-scope, open access journal publishing basic and applied
research that has impact for the benefit of society.

On the cover: In recent years, driven by the new round of scientific and technological revolution, the transportation industry is undergoing unprecedented and significant changes. Emerging transport vehicles include autonomous vehicle and flying car. Some innovative operational modes appear, like Mobility as a Service and shared mobility. Meanwhile, advanced informatics technology, such as Artificial Intelligence and the Internet of Things, is also joining the way to make a better traffic. All of the progress has facilitated the emergence of Advanced Urban Aerial Mobility, a new paradigm for future transportation. The system is based on providing high-quality services as its core and the principles of energy-saving and environmental protection, making urban travel more enjoyable. This common scene in science fiction is no longer far-reaching.

	Related comments

Add comment (English only)

Name*:
E-mail:
Telephone:
Code:
Comments*:

Position: Home > issue > Jan 30, 2023 Volume 4, Issue 2

Engineered extracellular vesicles for ischemic stroke treatment

Category: Letter Download:

PDF

Figure

Endnote

Author: Huitong Ruan, Yongfang Li, Dandan Zheng, Lianfu Deng, Gang Chen, Xingcai Zhang, Yaohui Tang, Wenguo Cui

Systemic administration of biologically engineered EVs for ischemic stroke

Nanotechnology-based therapeutic strategies have been proven effective in diseases including cancer, infection, inflammation, etc. However, the application of nanotechnology is greatly restricted in the treatment of central nervous system (CNS) disorders due to physiological CNS barriers. For example, the blood-brain barrier (BBB) can be the “Maginot line” for pharmacologically active molecules, blocking them out of the CNS. Besides, the neuroinflammation and non-directional differentiation of neural stem cells (NSCs) during neurological disorders could also affect neuronal activity and even produce fibrotic scars, thus hindering the CNS regeneration process.

Host

ISSN 2666-6758

Publishing partner

Journal links

Academic co-partner

	SHANGHAI INSTITUTE OF APPLIED PHYSICS, CAS
	INSTITUTE OF MICROBIOLOGY, CAS
	XI'AN INSTITUTE OF OPTICS AND PRECISION MECHANICS, CAS

Collections

Air Pollution
Astronomy
Cancer
Chemistry
COVID-19
Environment Changes
Geoscience
Life Sciences
Materials
Medicine
Physics
ScienceX / Interdiscipline

Stay connected

the.innovation.journal the.innovation.journal The Innovation TheInnovation创新 TheInnovation创新 The_Innovation office@the-innovation.org	Official： Astronomy： Chemistry： Geoscience： Informatics： Life Science： Management： Materials： Medicine： Physics： ScienceX：	@The_InnovationJ @Innov_Astronomy @InnovationChem @Innov_Geosci @Innov_inf @Innov_LifeSci @Innov_MGT @Innov_Materials @Innov_Medicine @InnovationPhys @Innov_ScienceX